bar

Endowed fellowships help create personal connections

When former Nashvillian Carol O’Hare speaks about a specific group of physicians at Vanderbilt-Ingram Cancer Center (VICC), her voice softens, and she refers to them affectionately as “my fellows.” Read More

Assembly shines light on VUMC’s many strengths

“Building an empowerment culture” was the theme of the Spring 2016 Clinical Enterprise Leadership Assembly at Vanderbilt University Medical Center (VUMC) for more than 900 staff and faculty leaders who attended the quarterly assembly at Langford Auditorium. Read More

Public invited to learn about VICC precision cancer medicine

Leading cancer investigators from Vanderbilt-Ingram Cancer Center will unveil the latest in cancer research during a community event May 10. Read More

First VICC cancer patient treated with new immunotherapy

For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system. Read More

Berkman, Schwarz join Vanderbilt Spine Center

Neurosurgeons Richard Alan Berkman, M.D., and Jacob Schwarz, M.D., have joined Vanderbilt Spine Center, where they will begin seeing patients March 1. Read More

Warner named medical director of Cancer Registry

Jeremy Warner, M.D., M.S., assistant professor of Medicine and Biomedical Informatics, has been named medical director of the Vanderbilt Cancer Registry at Vanderbilt-Ingram Cancer Center (VICC). Read More

Lovly lands cancer research grant from V Foundation

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been awarded a V Scholar Grant from the V Foundation for Cancer Research. Read More

Year in Review 2015: Leadership appointments bolster VUMC’s mission

Numerous key leadership roles at Vanderbilt University Medical Center were filled during the past year. Read More

VICC’s Horn lands Team Leadership Award from NCI

Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has received a 2015 Cancer Clinical Investigator Team Leadership Award (CCITLA) from the National Cancer Institute (NCI). Read More

VUMC and Incyte Corp. form new scientific alliance

Vanderbilt University Medical Center investigators have joined forces with scientists at Incyte Corp. to explore new therapies for the treatment of various types of cancer, as well as other diseases. The company has agreed to help fund basic and translational science research by VUMC investigators. Read More

Cancer therapies’ impact on heart, kidneys explored

Vanderbilt is embarking on a multi-disciplinary approach to understand how promising cancer treatments, specifically certain kinase inhibitors, affect the heart and kidneys. Read More

Providers, clinics lauded for patient satisfaction efforts

Three areas of Vanderbilt University Medical Center won Top Performer Awards in the 2015 Excellence in Healthcare Award, sponsored by Professional Research Consultants Inc. (PRC), Vanderbilt’s patient satisfaction surveyor until recently. Read More

New type of trial shows promise for several cancers

Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation. Read More

Rathmell to lead new Center for Immunobiology

Jeffrey Rathmell, Ph.D., has been recruited to Vanderbilt University Medical Center (VUMC) to lead a new Center for Immunobiology, a structure supported by the Department of Pathology, Microbiology and Immunology, the Department of Medicine and Vanderbilt-Ingram Cancer Center (VICC). Read More

New targeted therapy shows promise for rare joint tumor

Vanderbilt-Ingram Cancer Center (VICC) investigators and colleagues at several major medical centers have been testing a new targeted therapy that is showing promise for the treatment of a rare tumor that forms in and around joint cavities. Read More

Hyundai Hope On Wheels bolsters pediatric cancer fight

Debra Friedman, M.D., director of Pediatric Hematology/Oncology and E. Bronson Ingram Professor of Pediatric Oncology, has received a $50,000 Hyundai Hope On Wheels Impact grant recently for her track record in providing excellent patient care to families affected by pediatric cancer and to support a pediatric cancer program aimed at developing innovative therapies. Read More

Young professionals bolster cancer research efforts

With a basketball tucked under his arm, 7-year-old Roger Waynick climbed on top of his dad’s black Tahoe SUV with the intention of sailing upward through the air toward the basketball goal. He was poised to make the most epic dunk ever. Read More

Kitko to lead Pediatric Stem Cell Transplant Program

Carrie Kitko, M.D., has joined Monroe Carell Jr. Children’s Hospital at Vanderbilt as associate professor of Pediatrics and director of the Pediatric Stem Cell Transplant Program in the Division of Hematology/Oncology. Read More

Vanderbilt University honors 28 as emeriti faculty

Twenty-eight retiring faculty members were recognized during Vanderbilt’s Commencement ceremony May 8, when the university honored their years of service and bestowed on them the title of emeritus or emerita faculty. Read More

VICC’s Johnson to study cancer survivorship with immune inhibitor drugs

Douglas Johnson, M.D. Douglas Johnson, M.D., assistant professor of Medicine, has been named a recipient of the National Comprehensive Cancer… Read More